Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6672034 | 7360694 | I | 6672034-8 | 20100226 | 20100322 | 20100406 | EXP | TUK2010A00040 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 59 | YR | N | 20100405 | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6672034 | 1013462962 | PS | ACTOS | 1 | ORAL | (30 MG) ORAL | Y | U | 21073 | ||
| 6672034 | 1013537676 | C | ASPIRIN | 1 | |||||||
| 6672034 | 1013537696 | C | GLICLAZIDE (GLICLAZIDE) | 2 | |||||||
| 6672034 | 1013537697 | C | METFORMIN HCL | 1 | |||||||
| 6672034 | 1013537698 | C | SIMVASTATIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6672034 | 1013462962 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6672034 | DS |
| 6672034 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6672034 | MIGRAINE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6672034 | FGN |
| 6672034 | HP |
| 6672034 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6672034 | 1013462962 | 20100223 | 20100304 | 9 | DAY |